Fingerpaint Acquires MedThink
December 7, 2021
Fingerpaint, a biopharma commercialization partner, has acquired MedThink, a North Carolina–based medical communications firm, adding medical education, medical affairs communications, and publication services to its suite of capabilities. Financial terms were not disclosed; MedThink's president Scott Goudy will continue to lead day-to-day operations, and Knox Lane (a strategic investor in Fingerpaint) supported the transaction.
- Buyers
- Fingerpaint
- Targets
- MedThink
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.